Nathan Richard Zaccai

Nathan Richard Zaccai

Auto-generated profile, based on publicly available information

Nathan Richard Zaccai

Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LKLudek Koreny
Ludek Koreny
BMBrandon N Mercado-Saavedra
Brandon N Mercado-Saavedra
CKChristen M. Klinger
Christen M. Klinger
KBKonstantin Barylyuk
Konstantin Barylyuk
SBSimon Butterworth
Simon Butterworth
Ross WallerRoss Waller
Ross Waller
Apicomplexan parasites have immense impacts on humanity, but their basic cellular processes are often poorly understood. Where endocytosis occurs in these cells, how conserved this process is with other eukaryotes, and what the functions of endocytosis are across this phylum are major unanswered questions. Using the apicomplexan model Toxoplasma, we identified the molecular composition and behavior of unusual, fixed endocytic structures. Here, stable complexes of endocytic proteins differ markedly from the dynamic assembly/disassembly of these machineries in other eukaryotes. We identify that these endocytic structures correspond to the ‘micropore’ that has been observed throughout the Apicomplexa. Moreover, conserved molecular adaptation of this structure is seen in apicomplexans including the kelch-domain protein K13 that is central to malarial drug-resistance. We determine that a dominant function of endocytosis in Toxoplasma is plasma membrane homeostasis, rather than parasite nutrition, and that these specialized endocytic structures originated early in infrakingdom Alveolata likely in response to the complex cell pellicle that defines this medically and ecologically important ancient eukaryotic lineage.

14 February 2022 in Journal of the American Chemical Society
Verified
Journal Article
Open access
ASAndreas Santamaria
Andreas Santamaria
KBKrishna C. Batchu
Krishna C. Batchu
OMOlga Matsarskaia
Olga Matsarskaia
SPSylvain F. Prévost
Sylvain F. Prévost
DRDaniela Russo
Daniela Russo
NZNathan R. Zaccai
Nathan R. Zaccai
Coronavirus disease-2019 (COVID-19), a potentially lethal respiratory illness caused by the coronavirus SARS-CoV-2, emerged in the end of 2019 and has since spread aggressively across the globe. A thorough understanding of the molecular mechanisms of cellular infection by coronaviruses is therefore of utmost importance. A critical stage in infection is the fusion between viral and host membranes. Here, we present a detailed investigation of the role of selected SARS-CoV-2 Spike fusion peptides, and the influence of calcium and cholesterol, in this fusion process. Structural information from specular neutron reflectometry and small angle neutron scattering, complemented by dynamics information from quasi-elastic and spin–echo neutron spectroscopy, revealed strikingly different functions encoded in the Spike fusion domain. Calcium drives the N-terminal of the Spike fusion domain to fully cross the host plasma membrane. Removing calcium, however, reorients the peptide back to the lipid leaflet closest to the virus, leading to significant changes in lipid fluidity and rigidity. In conjunction with other regions of the fusion domain, which are also positioned to bridge and dehydrate viral and host membranes, the molecular events leading to cell entry by SARS-CoV-2 are proposed.

8 May 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GRGuto G. Rhys
Guto G. Rhys
CWChristopher W. Wood
Christopher W. Wood
JBJoseph L. Beesley
Joseph L. Beesley
NZNathan R. Zaccai
Nathan R. Zaccai
ABAntony J. Burton
Antony J. Burton
DWDerek N Woolfson
Derek N Woolfson

1 January 2016
Verified
Book Chapter
Closed access
NZNathan R. Zaccai
Nathan R. Zaccai
CSClifford W. Sandlin
Clifford W. Sandlin
JHJames T. Hoopes
James T. Hoopes
JCJoseph E. Curtis
Joseph E. Curtis
PFPatrick J. Fleming
Patrick J. Fleming
SKSusan Krueger
Susan Krueger

29 April 2022 in Science Advances
Verified
Journal Article
Open access
NZNathan R. Zaccai
Nathan R. Zaccai
ZKZuzana Kadlecova
Zuzana Kadlecova
VDVeronica Kane Dickson
Veronica Kane Dickson
KKKseniya Korobchevskaya
Kseniya Korobchevskaya
JKJan Kamenicky
Jan Kamenicky
LTLinton M. Traub
Linton M. Traub
Clathrin-mediated endocytosis (CME) is the main mechanism by which mammalian cells control their cell surface proteome. Proper operation of the pivotal CME cargo adaptor AP2 requires membrane-localized Fer/Cip4 homology domain-only proteins (FCHO). Here, live-cell enhanced total internal reflection fluorescence–structured illumination microscopy shows that FCHO marks sites of clathrin-coated pit (CCP) initiation, which mature into uniform-sized CCPs comprising a central patch of AP2 and clathrin corralled by an FCHO/Epidermal growth factor potential receptor substrate number 15 (Eps15) ring. We dissect the network of interactions between the FCHO interdomain linker and AP2, which concentrates, orients, tethers, and partially destabilizes closed AP2 at the plasma membrane. AP2’s subsequent membrane deposition drives its opening, which triggers FCHO displacement through steric competition with phosphatidylinositol 4,5-bisphosphate, clathrin, cargo, and CME accessory factors. FCHO can now relocate toward a CCP’s outer edge to engage and activate further AP2s to drive CCP growth/maturation.

18 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LPLuke A. Perera
Luke A. Perera
SPSteffen Preissler
Steffen Preissler
NZNathan R. Zaccai
Nathan R. Zaccai
Sylvain François PrevostSylvain François Prevost
Sylvain François Prevost
JDJuliette M. Devos
Juliette M. Devos
DRDavid Ron
David Ron
The endoplasmic reticulum (ER) Hsp70 chaperone BiP is regulated by AMPylation, a reversible inactivating post-translational modification. Both BiP AMPylation and deAMPylation are catalysed by a single ER-localised enzyme, FICD. Here we present crystallographic and solution structures of a deAMPylation Michaelis complex formed between mammalian AMPylated BiP and FICD. The latter, via its tetratricopeptide repeat domain, binds a surface that is specific to ATP-state Hsp70 chaperones, explaining the exquisite selectivity of FICD for BiP’s ATP-bound conformation both when AMPylating and deAMPylating Thr518. The eukaryotic deAMPylation mechanism thus revealed, rationalises the role of the conserved Fic domain Glu234 as a gatekeeper residue that both inhibits AMPylation and facilitates hydrolytic deAMPylation catalysed by dimeric FICD. These findings point to a monomerisation-induced increase in Glu234 flexibility as the basis of an oligomeric state-dependent switch between FICD’s antagonistic activities, despite a similar mode of engagement of its two substrates — unmodified and AMPylated BiP.